Download fulltext HTML
1.
Kerley M, Piri N, Ramasubramanian A. Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma. JOVR [Internet]. 2023Jul.23 [cited 2024May15];18(3):339–341. Available from: https://knepublishing.com/index.php/JOVR/article/view/13783

https://doi.org/10.18502/jovr.v18i3.13783

statistics

  • 459 Abstract Views
  • 340 PDF Views
  • 0 HTML Views

authors

  • Madison Kerley

    Madison Kerley

    Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, KY
  • Niloofar Piri

    Niloofar Piri

    Department of Ophthalmology, Saint Louis University, St. Louis, MO
  • Aparna Ramasubramanian

    Aparna Ramasubramanian

    Department of Ophthalmology, Phoenix Children’s Hospital, Phoenix, AZ

Published Date

  • Jul 23, 2023
This journal is publishing all the articles under Creative Commons Attribution License CC BY 4.0.

Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma

Journal of Ophthalmic and Vision Research (JOVR) / July–September 2023, Volume 18, Issue 3 / Pages 339–341

Abstract

This is a Photo Essay and does not have an abstract. Please download the PDF or view the article in HTML.

Keywords:

Not applicable

References
1. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986–2005. Arch Dermatol 2009;145:427–434.

2. Nakamura Y, Fujisawa Y. Diagnosis and management of acral lentiginous melanoma. Curr Treat Options Oncol 2018;19:42.

3. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractor metastatic melanoma. J Clin Oncol 2005;23:2346–2357.

4. Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, et al. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology 2009;116:98–989.

5. Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH. Diagnosis and classification of VogtKoyanagi-Harada disease. Autoimmun Rev 2014;13:550– 555.